A new targeted therapy medicine can extend the amount of time people with a subtype of glioma are on treatment without their cancer worsening, according to an international trial co-led by UCLA. The discovery provides a potential new therapeutic option for those suffering from the slow-growi
Researchers discovered that cancer frequently sends substances into the bloodstream that pathologically alter the liver, putting it in an inflammatory condition, causing fat to build up, and interfering with its regular detoxification functions.
Georgetown University's Lombardi Comprehensive Cancer Centre studied the microbiome of people with colorectal cancer and discovered that the bacteria, fungi, and viruses in a person's tumour differed significantly depending on whether they were diagnosed with early-onset disease (age 45 or y
Researchers at Weill Cornell Medicine found that cancer often releases molecules into the bloodstream that pathologically modify the liver, sending it into an inflammatory state, causing fat accumulation, and disrupting its typical detoxification processes. This finding sheds light on one of
When it comes to inspiration, it is frequently necessary to look within. According to a new study, cancer-fighting immune cells have discovered a method to do precisely that
A method that malignant tumours use to remotely prevent the emergence of an immune response that would halt their growth has been discovered by researchers at Baylor College of Medicine and associated institutions.
A study has found pediatric patients who receive more extended lymph node sampling during surgery for Wilms tumor, and other types of pediatric renal tumors, do not experience any more post-surgical complications.
Scientists at St. Jude Children's Research Hospital researched the effect of their environment to acquire a better grasp of the disparities between juvenile cancer patients when it comes to the effects of radiation therapy on cognition. Their research found that children who grew up in suppo
A recent study suggested that spinal cord stimulation (SCS) may be effective in lowering chronic pain in persons receiving active therapy with a standard anti-cancer medicine, according to researchers at Johns Hopkins University School of Medicine.
Children with recurrent brain tumours tolerated the first in-human trial of a novel immunotherapy well, and many were able to experience unexpected months of a more normal life, according to researchers. Immunotherapy disables a natural enzyme that tumours hijack for their defence.